{"nct_id":"NCT02307513","title":"A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease","status":"COMPLETED","status_verified_date":"2021-07","start_date":"2014-12-30","start_date_type":"ACTUAL","primary_completion_date":"2017-09-25","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}